393
Views
8
CrossRef citations to date
0
Altmetric
Commentary

Is There Emergence of β-Lactam Antibiotic-Resistant Streptococcus pyogenes in China?

ORCID Icon, ORCID Icon &
Pages 2323-2327 | Published online: 14 Jul 2020

References

  • Camara M, Dieng A, Boye CSB. Antibiotic susceptibility of Streptococcus pyogenes isolated from respiratory tract infections in Dakar, Senegal. Microbiol Insights. 2013;6:71–75. doi:10.4137/MBI.S1299624826076
  • Amábile-Cuevas CF, Hermida-Escobedo C, Vivar R. Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. Clin Infect Dis. 2001;null(Supplement_1):S30–32. doi:10.1086/319373
  • Capoor MR, Nair D, Deb M, et al. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India. Jpn J Infect Dis. 2006;59(5):334–336.17060703
  • Ogawa T, Terao Y, Sakata H, et al. Epidemiological characterization of Streptococcus pyogenes isolated from patients with multiple onsets of pharyngitis. FEMS Microbiol Lett. 2011;318(2):143–151. doi:10.1111/j.1574-6968.2011.02252.x21362024
  • Musser JM, Beres SB, Zhu L, et al. Reduced in vitro susceptibility of streptococcus pyogenes to β-lactam antibiotics associated with mutations in the pbp2x gene is geographically widespread. J Clin Microbiol. 2020;58(4):e01993–01919. doi:10.1128/JCM.01993-1931996443
  • Vannice K, Ricaldi J, Nanduri S, et al. Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to β-lactam antibiotics. Clin Infect Dis. 2019.
  • Shanghai surveillance of bacterial resistance working group. Surveillance of bacterial resistance in Shanghai. Chinese J Infect Chemother. 2002;2:1–9.
  • Zhu D, Wang F, Zhang Y. Surveillance of bacterial resistance in hospitals of Shanghai during 2005. Chinese J Infect Chemother. 2006;6:371–376.
  • Wang F. CHINET 2005 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2006;6:289–295.
  • Zhu D, Zhang Y, Wang F. Surveillance of bacterial resistance in Shanghai hospitals during 2006. Chinese J Infect Chemother. 2007;7:393–399.
  • Wang F. CHINET 2006 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2008;8:1–9.
  • Wang F, Zhu D, Hu F, et al. CHINET 2007 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2008;8:325–333.
  • Zhu D, Zhang Y, Wang F. Surveillance of bacterial resistance from hospitals in Shanghai in 2007. Chinese J Infect Chemother. 2008;8:401–410.
  • Wang J, Xiao Y. Mohnarin report 2006–2007: bacterial distribution and resistance in bloodstream infections. Chin J Nosocomiology. 2008;18:1238–1242.
  • Xiao Y, Wang J, Zhao C, et al. Mohnarin bacterial resistance surveillance 2006–2007. Chin J Nosocomiology. 2008;18:1051–1056.
  • Zhao C, Xiao Y. Mohnarin report 2006–2007: bacterial resistant surveillance among inpatients of non-ICU departments in China. Chin J Nosocomiology. 2008;18:1228–1232.
  • Wang J, Xiao Y. Mohnarin report 2006–2007: bacterial distribution and resistance in outpatients and emergency patients. Chin J Nosocomiology. 2008;18:1233–1237.
  • Wang C, Xue J, Zhang H, et al. Distribution and antibiotic resistance of Streptococcus spp.: results of national CHINET program 2007. Chinese J Infect Chemother. 2009;9:180–184.
  • Wang F, Zhu D, Hu F, et al. CHINET 2008 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2009;9:321–329.
  • Zhu D, Zhang Y, Wang F, et al. Surveillance of bacterial resistance from hospitals in Shanghai during 2008. Chinese J Infect Chemother. 2009;9:401–411.
  • Wang J, Xiao Y. 2008 Mohnarin report: results of Streptococcus, Haemophilus and Moraxella catarrhalis resistance. Chin J Antibiot. 2010;35:543–547.
  • Zhu D, Zhang Y, Wang F, et al. Surveillance report of bacterial resistance from hospitals in Shanghai in 2009. Chinese J Infect Chemother. 2010;10:403–413.
  • Wang C, Wang A, Zhang H, et al. CHINET 2009 surveillance of antibiotic resistance in Streptococcus spp. in China. Chinese J Infect Chemother. 2010;10:426–429.
  • Wang J, Xiao Y. 2008 Mohnarin report: bacterial drug resistance surveillance of emergency outpatients. Chin J Nosocomiology. 2010;20:2393–2398.
  • Zhu D, Wang F, Hu F, et al. CHlNET 2009 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2011;11:321–329.
  • Zhu D, Zhang Y, Wang F, et al. Surveillance of bacterial resistance in Shanghai hospitals during 2010. Chinese J Infect Chemother. 2011;11:436–445.
  • Zheng B, Lv Y, Wang S. Mohnarin report 2010: surveillance for antimicrobial resistance of gram-positive cocci. Chin J Nosocomiology. 2011;21:5128–5132.
  • Hu F, Zhu D, Wang F, et al. 2011 CHINET surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2012;12:321–329.
  • Zhang X, Yang Q, Sun H, et al. Surveillance of bacterial resistance in Peking Union Medical College Hospital during the period from 2005 to 2010. Chinese J Infect Chemother. 2012;12:330–339.
  • Luo J, Yang Q, Yu Y, et al. Distribution and antimicrobial resistance of common pathogens isolated from respiratory secretions in CHINET 2010 surveillance in China. Chinese J Infect Chemother. 2012;12:340–347.
  • Chen Y, Shen P, Wei Z, et al. Mohnarin report of 2010: surveillance of bacterial resistance of outpatient and emergency patients. Chin J Nosocomiology. 2012;22:491–496.
  • Xiao Y, Shen P, Wei Z, et al. Mohnarin report of 2011: monitoring of bacterial resistance in China. Chin J Nosocomiology. 2012;22:4946–4952.
  • Yang Q, Chen X, Kong H, et al. Mohnarin report of 2010: surveillance of bacterial resistance in patients under 14 years old. Chin J Nosocomiology. 2012;22:497–502.
  • Chen Y, Shen P, Wei Z, et al. Mohnarin report of 2011: bacterial resistance surveillance of emergency and outpatient isolates. Chin J Nosocomiology. 2012;22:5482–5487.
  • Yang Q, Chen X, Kong H, et al. Mohnarin report of 2011: surveillance of bacterial resistance in patients aged between 0 and 14. Chin J Nosocomiology. 2012;22:5488–5492.
  • Wang F, Zhu D, Hu F, et al. 2012 CHINET surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2013;13:321–330.
  • Zhou W, Kuang L, Su M, et al. 2012 annual report of Sichuan provincial antimicrobial resistant investigation net: surveillance of bacterial resistance in patients aged between 0 and 14. Pract J Clin Med. 2013;10:66–71.
  • Yang Y, Zhang L, Wang L, et al. Ministry of health national antimicrobial resistant investigation net report of 2011: bacterial resistance surveillance in patients under 14 years old. Chin J Clin Pharmacol. 2014;30:83–88.
  • Hu F, Zhu D, Wang F, et al. CHINET 2013 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2014;14:365–374.
  • Fan J, Dong L, Chen Z, et al. Clinical characteristics and antimicrobial resistance of invasive group A phemolytic streptococcus infection in children. Chin J Pediatr. 2014;52(1):46–50.
  • Hu F, Zhu D, Wang F, et al. CHINET 2014 surveillance of bacterial resistance in China. Chinese J Infect Chemother. 2015;15:401–410.
  • Hu F, Zhu D, Wang F, et al. Report of CHINET antimicrobial resistance surveillance program in 2015. Chinese J Infect Chemother. 2016;16:685–694.
  • Li Y, Lv Y, Xue F, et al. Antimicrobial susceptibility of gram-positive organisms: results from china antimicrobial resistance surveillance trial program, 2013–2014. Chin J Lab Med. 2016;39:120–129.
  • Hu F, Guo Y, Zhu D, et al. Antimicrobial resistance profile of clinical isolates in hospitals across China: report from the CHINET surveillance program, 2017. Chinese J Infect Chemother. 2018;18:241–251.